
- /
- Supported exchanges
- / BE
- / BSX.BE
BOSTON SCIENTIFIC (BSX BE) stock market data APIs
BOSTON SCIENTIFIC Financial Data Overview
There is no Profile data available for BSX.BE.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get BOSTON SCIENTIFIC data using free add-ons & libraries
Get BOSTON SCIENTIFIC Fundamental Data
BOSTON SCIENTIFIC Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BOSTON SCIENTIFIC News

CAH Strengthens Distribution With New Consumer Health Logistics Hub
Cardinal Health CAH recently unveiled its Consumer Health Logistics Center in Groveport, OH. This is a 350,000-square-foot facility designed to serve as a centralized replenishment hub for over-the-co...


GEHC Expands Women's Health Portfolio With AI-Enabled Voluson
GE HealthCare GEHC recently unveiled the Voluson Performance 18 and 16, the latest generation of ultrasound systems in its women’s health portfolio. The launch underscores the company’s commitment...

Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Boston Scientific (BSX) one of those stocks right now? A quick...

Oppenheimer Touts Boston Scientific Corporation (BSX) as the Best Large-Cap MedTech
Boston Scientific Corporation (NYSE:BSX) is one of the best defensive stocks to buy, according to Steve Cohen. On September 8, analysts at Oppenheimer upgraded the stock to an ‘Outperform’ from Pe...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.